Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|December 1, 2007
Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's diseaseMaria Laura Bolognesi, Andrea Cavalli, Luca Valgimigli, et al.Antioxidants (Basel, Switzerland)|August 27, 2021
A Nature-Inspired Nrf2 Activator Protects Retinal Explants from Oxidative Stress and NeurodegenerationMaria Grazia Rossino, Rosario Amato, Marialaura Amadio, et al.Bioorganic & Medicinal Chemistry|February 6, 2007
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moietiesVincenzo Tumiatti, Anna Minarini, Andrea Milelli, et al.Bioorganic & Medicinal Chemistry Letters|September 19, 2017
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIαElirosa Minniti, Jo Ann W Byl, Laura Riccardi, et al.Farmaco (Societa Chimica Italiana : 1989)|May 10, 2005
Heterocyclic inhibitors of AChE acylation and peripheral sitesMaria Laura Bolognesi, Vincenza Andrisano, Manuela Bartolini, et al.Bioorganic & Medicinal Chemistry|July 4, 2008
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinicsAnna Minarini, Gabriella Marucci, Cristina Bellucci, et al.Scientific Reports|September 10, 2016
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's DiseaseAngelo M Reggiani, Elena Simoni, Roberta Caporaso, et al.Journal of Medicinal Chemistry|October 31, 2003
Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptorsMichela Rosini, Alessandra Antonello, Andrea Cavalli, et al.Molecules (Basel, Switzerland)|November 14, 2023
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected TargetsFilippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, et al.ACS Chemical Neuroscience|April 20, 2017
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational ApproachElena Simoni, Melania M Serafini, Roberta Caporaso, et al.Pageof 8